體外肺模型市場：按類型、按應用分類 - 2025-2030 年全球預測

2023年體外肺模型市值為5.9159億美元，預計2024年將達到6.8938億美元，複合年成長率為16.94%，預計到2030年將達到17.7017億美元。

市場區隔是一個利基市場，但在更廣泛的生物製藥和醫療保健研究行業中正在不斷成長。這些模型是在細胞層面再現人類肺功能的人工系統，為藥物發現、毒性測試和疾病建模提供了有價值的工具。對試管內肺模型的需求源於其透過更好地模仿人類生理反應來加速藥物研究方法、減少對動物測試的依賴以及提高研究結果的準確性和適用性的潛力。應用範圍涵蓋藥物開發、個人化醫療和安全藥理學，最終用戶主要是製藥公司、研究機構和 CRO。

影響市場成長的關鍵因素包括氣喘和慢性阻塞性肺病等呼吸系統疾病盛行率的上升、組織工程的進步以及對動物試驗的倫理擔憂的增加。在個人化醫療和晶片器官技術等領域，在 3D 生物列印和先進生物材料等創新的推動下，忠實模擬人類肺部的機會正在增加。然而，挑戰仍然存在，可能會阻礙這些模型的最佳使用，特別是通訊協定標準化、高成本以及準確再現人類肺生理學各個方面的限制。

包括將人工智慧與體外肺模型相結合以提高資料分析的準確性，開發多器官模型以提供系統見解，以及利用微流體更準確地模擬體內環境等創新研究領域正在開拓。市場偏向創新主導，競爭中等至高度，深受技術進步和合作研究的影響。為了利用新的商機，相關人員專注於提高成本效率、提高模型準確性，並與科技公司建立策略夥伴關係，以突破當前體外技術所能實現的極限。

市場動態：快速發展的體外肺部模型市場的關鍵市場洞察

供需的動態交互作用正在改變體外肺模型市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

• 市場促進因素
  • 對動物試驗的道德替代方案的需求不斷成長
  • 藥物發現和開發的增加
  • 體外肺模型在疾病研究中的廣泛使用
• 市場限制因素
  • 開發和維護體外肺模型的高成本
• 市場機會
  • 個性化醫療的趨勢
  • 用於各種物質的毒性測試
• 市場挑戰
  • 與體外肺部模型相關的生理複雜性

波特五力：駕馭體外肺部模型市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解體外肺模型市場的外部影響

外部宏觀環境因素在塑造體外肺模型市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解體外肺模型市場的競爭狀況

對體外肺模型市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣體外肺部模型市場供應商績效評估

FPNV定位矩陣是評估體外肺部模型市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定體外肺模型市場成功之路的策略分析與建議

對於旨在加強其在全球市場的影響力的公司來說，對體外肺模型市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 對動物試驗的道德替代方案的需求增加
    • 藥物發現和開發的增加
    • 體外肺模型在疾病研究中的廣泛使用
  • 抑制因素
    • 開發和維持體外肺模型的成本很高。
  • 機會
    • 個性化醫療方法的趨勢
    • 用於各種物質的毒性測試
  • 任務
    • 與體外肺部模型相關的生理複雜性
• 市場區隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社群
  • 技術的
  • 合法地
  • 環境

第6章體外肺模型市場：依類型

• 2D模型
• 3D模型

第7章 體外肺模型市場：依應用分類

• 3D模型開發
• 藥物發現和毒理學
• 生理學調查
• 幹細胞研究與再生醫學

第8章 北美和南美體外肺模型市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太體外肺模型市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章歐洲、中東和非洲體外肺部模型市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
• 戰略分析和建議

公司名單

• AlveoliX AG
• Brainlab AG
• Cn Bio Innovations Limited
• Emulate, Inc.
• Epithelix Sarl
• Hologic, Inc.
• Horizon Discovery Group plc
• Insphero AG
• Lonza Group AG
• Mattek Corporation by Bico Group
• McKesson Corporation
• Merck KGaA
• MICA Information Systems, Inc.
• Mimetas BV
• PromoCell GmbH
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc
• Tissuse GmbH
• Varian Medical Systems, Inc

The In Vitro Lung Model Market was valued at USD 591.59 million in 2023, expected to reach USD 689.38 million in 2024, and is projected to grow at a CAGR of 16.94%, to USD 1,770.17 million by 2030.

The In Vitro Lung Model market represents a niche yet expanding segment within the broader biopharmaceutical and healthcare research industry. These models are engineered systems that replicate human lung function at a cellular level, providing a valuable tool for drug discovery, toxicity testing, and disease modeling. The necessity for in vitro lung models arises from their potential to expedite pharmaceutical research processes, reduce reliance on animal testing, and better mimic human physiological responses, thereby enhancing the accuracy and applicability of research findings. Applications extend across drug development, personalized medicine, and safety pharmacology, with end-users primarily including pharmaceutical companies, research institutions, and CROs.

Key factors influencing market growth include the rising prevalence of respiratory diseases like asthma and COPD, advancements in tissue engineering, and growing ethical concerns over animal testing. There are notable opportunities in segments such as personalized medicine and organ-on-chip technology, driven by innovations like 3D bioprinting and advanced biomaterials that increasingly simulate human lungs with high fidelity. However, challenges remain, particularly in standardization of protocols, high costs, and limitations in accurately replicating all facets of human lung physiology which could restrain optimal use of these models.

Innovative research areas ripe for exploration include the integration of artificial intelligence with in vitro lung models to enhance data analysis accuracy, development of multi-organ models that provide systemic insights, and the utilization of microfluidics to simulate in vivo environments more accurately. The market leans towards being innovation-driven with a moderate-to-high degree of competition, largely influenced by technological advancements and collaborations. To capitalize on emerging opportunities, stakeholders must focus on increasing cost-effectiveness, improving model accuracy, and forging strategic partnerships with technology firms to push the boundaries of what's achievable with current in vitro technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In Vitro Lung Model Market

The In Vitro Lung Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for ethical alternatives to animal testing
  • Increase in drug discovery and development
  • Extensive use of in-viro lung model in disease research
• Market Restraints
  • High cost of development and maintainence of in-vitro lung model
• Market Opportunities
  • Inclination toward personalized medicine approach
  • Utilization for toxicity testing of various substances
• Market Challenges
  • Physiological complexity associated with in-vitro lung model

Porter's Five Forces: A Strategic Tool for Navigating the In Vitro Lung Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In Vitro Lung Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In Vitro Lung Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In Vitro Lung Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In Vitro Lung Model Market

A detailed market share analysis in the In Vitro Lung Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In Vitro Lung Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In Vitro Lung Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In Vitro Lung Model Market

A strategic analysis of the In Vitro Lung Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In Vitro Lung Model Market, highlighting leading vendors and their innovative profiles. These include AlveoliX AG, Brainlab AG, Cn Bio Innovations Limited, Emulate, Inc., Epithelix Sarl, Hologic, Inc., Horizon Discovery Group plc, Insphero AG, Lonza Group AG, Mattek Corporation by Bico Group, McKesson Corporation, Merck KGaA, MICA Information Systems, Inc., Mimetas B.V., PromoCell GmbH, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc, Tissuse GmbH, and Varian Medical Systems, Inc.

Market Segmentation & Coverage

This research report categorizes the In Vitro Lung Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across 2D Models and 3D Models.
• Based on Application, market is studied across 3D Model Development, Drug Discovery & Toxicology, Physiological Research, and Stem Cell Research & Regenerative Medicine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for ethical alternatives to animal testing
    • 5.1.1.2. Increase in drug discovery and development
    • 5.1.1.3. Extensive use of in-viro lung model in disease research
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development and maintainence of in-vitro lung model
  • 5.1.3. Opportunities
    • 5.1.3.1. Inclination toward personalized medicine approach
    • 5.1.3.2. Utilization for toxicity testing of various substances
  • 5.1.4. Challenges
    • 5.1.4.1. Physiological complexity associated with in-vitro lung model
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. In Vitro Lung Model Market, by Type

• 6.1. Introduction
• 6.2. 2D Models
• 6.3. 3D Models

7. In Vitro Lung Model Market, by Application

• 7.1. Introduction
• 7.2. 3D Model Development
• 7.3. Drug Discovery & Toxicology
• 7.4. Physiological Research
• 7.5. Stem Cell Research & Regenerative Medicine

8. Americas In Vitro Lung Model Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific In Vitro Lung Model Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa In Vitro Lung Model Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AlveoliX AG
• 2. Brainlab AG
• 3. Cn Bio Innovations Limited
• 4. Emulate, Inc.
• 5. Epithelix Sarl
• 6. Hologic, Inc.
• 7. Horizon Discovery Group plc
• 8. Insphero AG
• 9. Lonza Group AG
• 10. Mattek Corporation by Bico Group
• 11. McKesson Corporation
• 12. Merck KGaA
• 13. MICA Information Systems, Inc.
• 14. Mimetas B.V.
• 15. PromoCell GmbH
• 16. STEMCELL Technologies Inc.
• 17. Thermo Fisher Scientific Inc
• 18. Tissuse GmbH
• 19. Varian Medical Systems, Inc

LIST OF FIGURES

• FIGURE 1. IN VITRO LUNG MODEL MARKET RESEARCH PROCESS
• FIGURE 2. IN VITRO LUNG MODEL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IN VITRO LUNG MODEL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. IN VITRO LUNG MODEL MARKET DYNAMICS
• TABLE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D MODELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D MODEL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHYSIOLOGICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL RESEARCH & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. POLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2023